MedicarePartD.guide

A non-government resource built from CMS public data

Hepatitis C drugs on every 2026 California Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in California cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

Hepatitis C drugs by 2026 California Part D plan
DrugHealthSpring Assurance Rx$0.00/moS5617-158Wellcare Value Script$5.70/moS4802-163Wellcare Classic$6.20/moS4802-094HealthSpring Extra Rx$70.60/moS5617-382SilverScript Choice$103.60/moS5601-064Humana Value Rx Plan$104.60/moS5884-211AARP Medicare Rx Saver from UHC$109.40/moS5921-376Humana Basic Rx Plan$132.20/moS5884-114AARP Medicare Rx Preferred from UHC$165.40/moS5921-413Humana Premier Rx Plan$172.90/moS5884-178Blue Shield Rx Plus$199.70/moS2468-003Blue Shield Rx Enhanced$227.80/moS2468-004
Epclusasofosbuvir and velpatasvirTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA25%QL 28/28dTier 5PA25%Tier 5PA26%QL 28/28dNot coveredTier 5PA25%QL 28/28dNot coveredTier 5PA33%QL 28/28dNot coveredNot covered
sofosbuvir-velpatasvirgeneric EpclusaNot coveredTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dNot coveredNot coveredNot coveredTier 5PA25%QL 28/28dNot coveredTier 5PA31%QL 28/28dNot coveredNot coveredNot covered
Mavyretglecaprevir and pibrentasvirNot coveredNot coveredNot coveredNot coveredTier 5PA25%Not coveredTier 5PA25%QL 140/28dNot coveredTier 5PA31%QL 140/28dNot coveredTier 5PA25%QL 6/1dTier 5PA33%QL 6/1d
Harvoniledipasvir and sofosbuvirTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA25%QL 28/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ledipasvir-sofosbuvirgeneric HarvoniNot coveredTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
VosevisofosbuvirTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dTier 5PA26%QL 28/28dTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dTier 5PA31%QL 28/28dTier 5PA33%QL 28/28dTier 5PA25%QL 1/1dTier 5PA33%QL 1/1d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.